Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Protein farnesyltransferase inhibitors described by Warner-Lambert

July 26, 1996

IL-2/interferon alpha/5-FU combination effective against metastatic renal cancer

July 26, 1996

Aphton announces commencement of phase III trials for Gastrimmune

July 26, 1996

O6-alkylguanine-DNA alkyltransferase inactivators disclosed

July 19, 1996

Suppressin from pituitary extract described by the University of Alabama

July 19, 1996

Cell-cell adhesion-regulating proteins as antitumor treatment

July 19, 1996

Potent selective protein farnesyltransferase inhibitor from Pierre Fabre

July 19, 1996

Clarion's CPR-1007 shows antitumor, antipsoriatic and antiinflammatory activity

July 19, 1996

Alfacell's Onconase warrants combination therapy studies

July 19, 1996

More anthracycline antibiotics from Mercian

July 19, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...